K. Sudheer
Research Scholar, Sunrise University, Alwar
Gulab Singh
Professor, Sunrise University, Alwar
Abstract
The global outbreak of COVID-19, caused by the novel coronavirus SARS-CoV-2, has thrust the world into an unprecedented health crisis. In the quest for effective treatments and preventive measures, the antiviral potential of plants has emerged as a promising avenue of exploration. This study delves into the diverse array of plant-derived compounds and extracts that exhibit antiviral properties against SARS-CoV-2 and explores their potential contributions to managing and mitigating the COVID-19 pandemic. Plants have evolved an astonishing variety of secondary metabolites, including alkaloids, flavonoids, terpenoids, and polyphenols, many of which possess antiviral properties. These natural compounds have demonstrated the ability to inhibit viral replication, block viral entry, and modulate host immune responses. The antiviral potential of plants against COVID-19 represents a convergence of traditional wisdom and modern science. Nature's pharmacopeia, with its wealth of bioactive compounds and therapeutic knowledge, offers a multifaceted approach to managing and mitigating viral pandemics. As we navigate the complexities of the COVID-19 pandemic, harnessing the potential of plant-derived antivirals, while ensuring responsible sourcing and research rigor, holds promise for enhancing our arsenal of strategies against viral threats.
Keywords: COVID-19, pharmacopeia, traditional, pandemics, knowledge